Detalhe da pesquisa
1.
A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer.
Prostate
; 2018 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29882250
2.
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
Cancer Immunol Res
; 12(6): 704-718, 2024 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552171